PARK7 Catalyzes Stereospecific Detoxification of Methylglyoxal Consistent with Glyoxalase and Not Deglycase Function
Biochemistry · 2023
DOI: 10.1021/acs.biochem.3c00325 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemistry, 2023. Verfasst von John S Coukos und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, The University of Chicago, 929 E. 57th Street, Chicago, Illinois 60637, United States. Hauptthemen laut MEDLINE: Pyruvaldehyde, Parkinson Disease. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NCI NIH HHS, Division of Chemistry.
Abstract (Originalsprache)
The protein PARK7 (also known as DJ-1) has been implicated in several diseases, with the most notable being Parkinson's disease. While several molecular and cellular roles have been ascribed to DJ-1, there is no real consensus on what its true cellular functions are and how the loss of DJ-1 function may contribute to the pathogenesis of Parkinson's disease. Recent reports have implicated DJ-1 in the detoxification of several reactive metabolites that are produced during glycolytic metabolism, with the most notable being the α-oxoaldehyde species methylglyoxal. While it is generally agreed that DJ-1 is able to metabolize methylglyoxal to lactate, the mechanism by which it does so is hotly debated with potential implications for cellular function. In this work, we provide definitive evidence that recombinant DJ-1 produced in human cells prevents the stable glycation of other proteins through the conversion of methylglyoxal or a related alkynyl dicarbonyl probe to their corresponding α-hydroxy carboxylic acid products. This protective action of DJ-1 does not require a physical interaction with a target protein, providing direct evidence for a glutathione-free glyoxalase and not a deglycase mechanism of methylglyoxal detoxification. Stereospecific liquid chromatography-mass spectrometry (LC-MS) measurements further uncovered the existence of nonenzymatic production of racemic lactate from MGO under physiological buffer conditions, whereas incubation with DJ-1 predominantly produces l-lactate. Collectively, these studies provide direct support for the stereospecific conversion of MGO to l-lactate by DJ-1 in solution with negligible or no contribution of direct protein deglycation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, The University of Chicago, 929 E. 57th Street, Chicago, Illinois 60637, United States.
- University of Chicago Medicine Comprehensive Cancer Center Metabolomics Platform, The University of Chicago, 900 E. 57th Street, Chicago, Illinois 60637, United States.
ORCID-Profile: Hardik Shah, Raymond E Moellering
Förderung
- NIGMS NIH HHS
- NCI NIH HHS
- Division of Chemistry
- National Cancer Institute
- Alfred P. Sloan Foundation
- National Institute of General Medical Sciences
Zitieren
APA
Coukos, J. S., Lee, C. W., Pillai, K. S., Shah, H., & Moellering, R. E. (2023). PARK7 Catalyzes Stereospecific Detoxification of Methylglyoxal Consistent with Glyoxalase and Not Deglycase Function. Biochemistry. https://doi.org/10.1021/acs.biochem.3c00325
Vancouver
Coukos JS, Lee CW, Pillai KS, Shah H, Moellering RE. PARK7 Catalyzes Stereospecific Detoxification of Methylglyoxal Consistent with Glyoxalase and Not Deglycase Function. Biochemistry. 2023. doi:10.1021/acs.biochem.3c00325
BibTeX
@article{Coukos2023,
author = {Coukos, John S and Lee, Chris W and Pillai, Kavya S and Shah, Hardik and Moellering, Raymond E},
title = {PARK7 Catalyzes Stereospecific Detoxification of Methylglyoxal Consistent with Glyoxalase and Not Deglycase Function},
journal = {Biochemistry},
year = {2023},
doi = {10.1021/acs.biochem.3c00325}
}
EUVIMED